Daiichi Sankyo / AstraZeneca - A new horizon for HER2 expressing breast cancer
(ID 1)
Calendar Export
Will new definitions for HER2 status make a difference for my patients? - An Oncologist’s perspective
(ID 286)
Lecture Time
18:30 - 18:30
Speakers
Veronique Dieras
(Rennes, France)
Authors
Veronique Dieras
(Rennes, France)
Session Name
Daiichi Sankyo / AstraZeneca - A new horizon for HER2 expressing breast cancer
(ID 1)
Room
Frankfurt Hall
Date
Wed, 04.05.2022
Time
18:30 - 19:30